MedTrace Logo

Impact of Diverticular Disease on the Detection of Colon Adenomas

NCT02057562 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2016-11-21

No results posted yet for this study

Summary

Benign adenomas of the colon have the potential to degenerate and become malignant. Therefore adenomatous polyps should be detected and resected during colonoscopy. Factors like advanced age and male gender are associated with the detection of adenomas. The same epidemiological pattern can be found with regard to colon diverticula. Furthermore, western world countries report higher incidences of both colorectal carcinoma as well as diverticular disease. It is not known whether a correlation exists between both entities. Some recent data have postulated higher adenoma detection rates in patients with concomitant diverticular disease (Rondagh EJ et al. Eur J Gastroenterol Hepatol. 2011; 23:1050-5. Kieff BJ et al. Am J Gastroenterol 2004; 99: 2007-11). If a positive correlation could be found this would possibly affect recommendations regarding colonoscopy surveillance intervals for patients with and without diverticular disease. The investigators therefore plan to conduct the following trial.

Conditions

  • Colon Adenoma
  • Diverticulosis

Sponsors & Collaborators

  • Technical University of Munich

    lead OTHER

Principal Investigators

  • Peter Klare, MD · II. Medizinische Klinik, Klinikum rechts der Isar der Technischen Universität München, Germany

  • Peter Born, Prof. Dr. · Innere Medizin II, Rotkreuzklinikum München, Nymphenburger Str. 163, München, Germany

  • Stefan von Delius, MD · II. Medizinische Klinik, Klinikum rechts der Isar der Technischen Universität München, Germany

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2016-09-30
Completion
2017-03-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02057562 on ClinicalTrials.gov